12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry.

Authors:
Niedzwiecki M; Hunt A; Nguyen V; Mehta H; Creuzot-Garcher C and 7 more

Journal:
Acta Ophthalmol

Publication Year: 2021

DOI:
10.1111/aos.15014

PMCID:
PMC9292733

PMID:
34519167

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Ophthalmol

Abbreviation: Acta Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
Liisborg C. (2022) - Transparency Score: 1/6
Air versus fluorinated gas tamponades in pars plana vitrectomy treatment for primary rhegmatogenous…
Govers BM; Lamers MPM; Klevering BJ and 1 more (2022) - Transparency Score: 2/6
Antenatal and neonatal factors and morphology of the optic nerve head in the Northern Finland birth…
Pitkänen J; Leiviskä I; Liinamaa J and 1 more (2022) - Transparency Score: 3/6
A prognostic classification system for uveal melanoma based on a combination of patient age and sex…
Gill VT; Sabazade S; Herrspiegel C and 9 more (2022) - Transparency Score: 2/6
Automated artificial intelligence-based system for clinical follow-up of patients with age-related …
Potapenko I; Thiesson B; Kristensen M and 5 more (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This work was supported by a grant from the Royal Australian NZ College of Ophthalmologists Eye Foundation (2007‐2009) and a grant from the National Health and Medical Research Council, Australia (NHMRC 2010‐1012)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025